Regeneron Investigational Site — North Dartmouth, Massachusetts

Regeneron Investigational Site is a clinical research site located in North Dartmouth, Massachusetts, United States 02747.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Regeneron Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Allergic Rhinitis.

Sponsors: Regeneron Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in North Dartmouth

Browse all research sites in Massachusetts · View every site in North Dartmouth

• Southcoast Hospital
• NorthEast Medical Research Associates
• GSK Investigational Site
• Research Site
• Infinity Medical Research
• Pfizer Investigational Site
• Novartis Investigative Site
• Boston Neuro Research Center
• Novo Nordisk Investigational Site
• Forest Investigative Site 1029
• Clinical Research Site
• Forest Investigative Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Regeneron Investigational Site?

Regeneron Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Regeneron Investigational Site conducted?

Regeneron Investigational Site has 1 clinical trials on record. Their work covers Allergic Rhinitis.

Is Regeneron Investigational Site accredited by Crixeo Clinical Trials?

Regeneron Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Regeneron Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.